MGLMX
Price
$16.63
Change
+$0.05 (+0.30%)
Updated
Dec 3 closing price
Net Assets
2.2B
NGREX
Price
$10.34
Change
+$0.02 (+0.19%)
Updated
Dec 3 closing price
Net Assets
726.16M
Interact to see
Advertisement

MGLMX vs NGREX

Header iconMGLMX vs NGREX Comparison
Open Charts MGLMX vs NGREXBanner chart's image
MFS Global Real Estate R4
Price$16.63
Change+$0.05 (+0.30%)
VolumeN/A
Net Assets2.2B
Northern Global Real Estate Index
Price$10.34
Change+$0.02 (+0.19%)
VolumeN/A
Net Assets726.16M
MGLMX vs NGREX Comparison Chart in %
View a ticker or compare two or three
VS
MGLMX vs. NGREX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGLMX is a Buy and NGREX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MGLMX has more cash in the bank: 2.2B vs. NGREX (726M). NGREX pays higher dividends than MGLMX: NGREX (2.97) vs MGLMX (2.48). MGLMX was incepted earlier than NGREX: MGLMX (11 years) vs NGREX (19 years). MGLMX (0.95) is less costly to investors than NGREX (0.48). MGLMX is a more actively managed with annual turnover of: 48.00 vs. NGREX (8.98). MGLMX has a lower initial minimum investment than NGREX: MGLMX (0) vs NGREX (2500). NGREX annual gain was more profitable for investors over the last year : 4.58 vs. MGLMX (-3.00). NGREX return over 5 years is better than : 17.00 vs. MGLMX (1.78).
MGLMXNGREXMGLMX / NGREX
Total Expense Ratio0.940.47200%
Annual Report Gross Expense Ratio0.950.48198%
Fund Existence11 years19 years-
Gain YTD3.54910.68533%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets2.2B726M303%
Annual Yield % from dividends2.482.9783%
Returns for 1 year-3.004.58-66%
Returns for 3 years2.9921.3414%
Returns for 5 years1.7817.0010%
Returns for 10 years24.7446.0654%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CPOCX19.270.47
+2.50%
Morgan Stanley Insight L
DTCAX21.060.04
+0.19%
BNY Mellon Sust US Equity A
PCAQX92.620.09
+0.10%
Principal Capital Appreciation R5
IPHYF1.99N/A
N/A
Innate Pharma
PRPRF0.02N/A
N/A
Prairie Provident Resources Inc